Safety concerns included uncharacterized immunogenicity risks, inadequate impurity and endotoxin testing in available raw material, the unresolved free-base versus acetate salt form distinction, and, for BPC-157 specifically, an angiogenesis mechanism that raises theoretical concerns for patients with undiagnosed tumors
Compounded medications are not FDA-approved as finished products, but they are prepared by licensed 503A compounding pharmacies regulated by state boards and the FDA
Sci Transl Med 2013;5:209ra151.ArticlePubMed 5
Driving and using machines: Retatrutide is unlikely to affect your ability to drive and use machines
How many XERF sessions will I need
If you are currently using other weight management medications or supplements alongside GLP-1 drugs , discuss adding Activate with your provider to avoid potential interactions